In addition, it was found that genetic mutations of SCN5A variants, including Nav1.5, determine INa and the development of both the LQTS and Brugada syndromes (Tse et al., 2017; Li et al., 2018). This evidence concerns the gene SCN5A and familial long QT syndrome.